﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Journal of Cardiovascular and Thoracic Research</JournalTitle>
      <Issn>2008-5117</Issn>
      <Volume>5</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2013</Year>
        <Month>07</Month>
        <DAY>13</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Oxidative Versus Thrombotic Stimulation of Platelets Differentially activates Signalling Pathways</ArticleTitle>
    <FirstPage>61</FirstPage>
    <LastPage>65</LastPage>
    <ELocationID EIdType="doi">10.5681/jcvtr.2013.013</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Pouran</FirstName>
        <LastName>Karimi</LastName>
      </Author>
      <Author>
        <FirstName>Nadereh</FirstName>
        <LastName>Rashtchizadeh</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.5681/jcvtr.2013.013</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2013</Year>
        <Month>04</Month>
        <Day>17</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Atherosclerosis is one of the inflammatory underlying disease associated by oxidative stress and thrombotic agents. This study aimed to evaluate the potential role of cupper oxidized low-density lipoprotein (OxLDL) and thrombin for inducing mitogen activated protein kinases (MAPKs) in platelets. Methods: Phosphorylation of P38MAPK, Jun N-terminal Kinase (JNK), and Extracellular signal-regulated kinases (ERK1/2) and P-selectin expression were determined in lysates of washed human platelets pretreated with low doses of thrombin and cu2+-OxLDL By Enzyme-linked immunosorbent assay (ELISA). Pharmacological inhibition was performed by SB203580, PD980559 and SP6000125 for P38MAPK, ERK1/2 and JNK activity, respectively. The ratio of phosphorylated to total protein was used for normalizing the phospho proteins contents of cells. Results: OxLDL and thrombin significantly and differentially increased P-selectin expression (P&lt;0.05), P38MAPK (P&lt;0.05) and c-JNK (P&lt;0.05) and ERK1/2 (P&lt;0.05) phosphorylation in platelets. SB 203580 and SP6000125 significantly decreased P-selectin expression in both oxidative (P&lt;0.05) and thrombotic (P&lt;0.05) activated platelets. Conclusion: Our results indicated that MAPK inhibitors can reduce atherothrombotic events via alterations in P-selectin expression suggesting that these inhibitors may be useful in the inhibition of atheroma development.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Atherosclerosis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">C-Jun N-terminal Kinase Extracellular</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Signal-regulated Kinase</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">P38-Mitogen Activated Protein Kinase</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">P-selectin</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>